This Program Project is focused on examining the pathogenesis of experimental diabetic autoimmunity. Four investigators have coordinated and integrated their efforts, so to jointly gain an understanding of how T cells cause autoimmunity to beta cells. Drs. Emil Unanue and Osami Kanagawa have a joint project that examines the biochemical properties of the class II MHC molecule (I-Ag7) of the NOD mouse, the most important molecule required for the spontaneous development of diabetes. Their initial data indicates that I-Ag7 are weak peptide-binding class II molecules. project I evaluate the chemistry of I-Ag7, its binding properties and attempts to correlate these properties with T cell biology. The second project is by Dr. Jonathan Katz who has developed a T cell receptor bearing transgenic mice. The receptor is from a diabetogenic T cell clone reactive with a molecule of the beta cell granule. Dr. Katz has just published that skewing of these T cells towards a Th1 cytokine profile favors the development of diabetes. His present endeavors are to understand the transition from peri-insulitis to a diabetic stage, to examine how the state of T cell differentiation leads to pathology, to examine the effects of Th2 differentiation and the role of CD8 in diabetes, all of this using the powerful tool of a T cell receptor transgenic NOD mouse. Dr. Kenneth Murphy has been studying the molecular basis of Th1/Th2 differentiation, and has recently used another T cell receptor transgenic mice to follow their differentiation to Th1 or Th2 phenotype. Dr. Murphy proposes to examine the genetic basis of the response of undifferentiated T cells to Th1 or Th2 subset. He has definite evidence that unknown genes regulate the response to cytokines by altering the response to IL-12. Both Katz and Murphy argue that an understanding of the biology and molecular basis of T cell subset differentiation will be vital for the development, and control, of diabetic autoimmune reactions. All four investigators have projects that are truly synergistic and which will benefit from their joint efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI039676-03
Application #
2672749
Study Section
Special Emphasis Panel (ZAI1-PSS-I (42))
Program Officer
Akolkar, Beena
Project Start
1996-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ranganath, S; Murphy, K M (2001) Structure and specificity of GATA proteins in Th2 development. Mol Cell Biol 21:2716-25
Farrar, J D; Smith, J D; Murphy, T L et al. (2000) Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2. J Biol Chem 275:2693-7
Murphy, T L; Geissal, E D; Farrar, J D et al. (2000) Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation. Mol Cell Biol 20:7121-31
Carter, L L; Murphy, K M (1999) Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J Exp Med 189:1355-60
Pakala, S V; Chivetta, M; Kelly, C B et al. (1999) In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189:1053-62
Yang, J; Murphy, T L; Ouyang, W et al. (1999) Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol 29:548-55
Guler, M L; Gorham, J D; Dietrich, W F et al. (1999) Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism. J Immunol 162:1339-47
Ouyang, W; Ranganath, S H; Weindel, K et al. (1998) Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745-55
Gorham, J D; Guler, M L; Fenoglio, D et al. (1998) Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J Immunol 161:1664-70
Kurrer, M O; Pakala, S V; Hanson, H L et al. (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 94:213-8

Showing the most recent 10 out of 14 publications